Welcome to LookChem.com Sign In|Join Free

CAS

  • or

123530-67-6

Post Buying Request

123530-67-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

123530-67-6 Usage

Description

2-Propenoic acid, 3-(2-benzothiazolyl)-, (E)-(9CI) is a chemical compound with the molecular formula C13H9NOS. It is a derivative of acrylic acid and contains a benzothiazole moiety. 2-Propenoicacid,3-(2-benzothiazolyl)-,(E)-(9CI) exists as a clear, colorless liquid and is primarily used as an intermediate in the production of various organic compounds. Due to its unique structural properties and reactivity, it has potential applications in the field of organic synthesis and material science. It is important to handle this compound with caution and follow proper safety protocols when working with it.

Uses

Used in Pharmaceutical Industry:
2-Propenoic acid, 3-(2-benzothiazolyl)-, (E)-(9CI) is used as an intermediate in the synthesis of pharmaceuticals. Its unique structure and reactivity make it important for the development of new drugs and medicinal compounds.
Used in Agrochemical Industry:
2-Propenoicacid,3-(2-benzothiazolyl)-,(E)-(9CI) is also used as an intermediate in the production of agrochemicals. Its properties allow for the creation of new and effective pesticides, herbicides, and other agricultural chemicals.
Used in Materials Science:
2-Propenoic acid, 3-(2-benzothiazolyl)-, (E)-(9CI) has potential applications in materials science. Its unique structure and reactivity can be utilized in the development of new materials with specific properties for various applications.
Used in Organic Synthesis:
As an intermediate in organic synthesis, this compound can be used to create a variety of organic compounds for different industries, including pharmaceuticals, agrochemicals, and materials science. Its versatility and reactivity make it a valuable component in the synthesis of new and innovative products.

Check Digit Verification of cas no

The CAS Registry Mumber 123530-67-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,5,3 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 123530-67:
(8*1)+(7*2)+(6*3)+(5*5)+(4*3)+(3*0)+(2*6)+(1*7)=96
96 % 10 = 6
So 123530-67-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H7NO2S/c12-10(13)6-5-9-11-7-3-1-2-4-8(7)14-9/h1-6H,(H,12,13)/b6-5+

123530-67-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (CBR01227)  (2E)-3-(1,3-Benzothiazol-2-yl)acrylic acid  AldrichCPR

  • 123530-67-6

  • CBR01227-1G

  • 966.42CNY

  • Detail

123530-67-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (2E)-3-(1,3-BENZOTHIAZOL-2-YL)ACRYLIC ACID 95%

1.2 Other means of identification

Product number -
Other names Dominal hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:123530-67-6 SDS

123530-67-6Relevant articles and documents

CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS

-

Page 103, (2010/02/08)

This invention pertains to certain carbamic acid compounds of the following formula, which inhibit HDAC (histone deacetylase) activity wherein: A is independently an unsubstituted or substituted bicyclic C9-10heteroaryl group (e.g., quinolinyl; quinoxalinyl; benzoxazolyl; benzothiazolyl); Q is an acid leader group, and is independently an unsubstituted or substituted, saturated or unsaturated C1 7alkylene group having a backbone length of 4 or less; with the proviso that if A is unsubstituted benzothiazol-2-yl, then Q is an unsaturated group; and with the proviso that if A is unsubstituted quinolin-6-yl, then Q is unsubstituted at the α-position; and with the proviso that A is not benzimidazol-2-yl; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, and prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both invitro and in vivo, to inhibit HDAC, and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, etc.

Acrylamide derivatives as antiallergic agents. III. Synthesis and structure-activity relationships of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]- and N-[4-(4-diphenylmethylene-1-piperidyl)butyl]-3-heteroarylacrylamides

Nishikawa,Shindo,Ishii,Nakamura,Kon,Uno

, p. 684 - 687 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 123530-67-6